Innate Pharma
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
330 disclosures on record
Evolution of the disclosed total
0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
April 15, 2014 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| January 19, 2018 | Numeric Investors LLC | 0.49% | January 23, 2018 |
| January 15, 2018 | GSA Capital Partners LLP | 0.61% | April 16, 2018 |
| January 2, 2018 | Marshall Wace LLP | 0.48% | January 4, 2018 |
| December 27, 2017 | GSA Capital Partners LLP | 0.50% | April 16, 2018 |
| December 22, 2017 | Numeric Investors LLC | 0.59% | January 23, 2018 |
| December 22, 2017 | GSA Capital Partners LLP | 0.49% | December 27, 2017 |
| December 21, 2017 | GSA Capital Partners LLP | 0.71% | December 27, 2017 |
| December 18, 2017 | Numeric Investors LLC | 0.69% | January 23, 2018 |
| December 15, 2017 | Marshall Wace LLP | 0.58% | January 4, 2018 |
| December 13, 2017 | Numeric Investors LLC | 0.76% | January 23, 2018 |
| December 11, 2017 | Marshall Wace LLP | 0.64% | January 4, 2018 |
| December 8, 2017 | GSA Capital Partners LLP | 0.60% | December 27, 2017 |
| December 1, 2017 | Numeric Investors LLC | 0.97% | January 23, 2018 |
| November 30, 2017 | Numeric Investors LLC | 1.00% | January 23, 2018 |
| November 28, 2017 | Numeric Investors LLC | 0.91% | January 23, 2018 |
| November 27, 2017 | Numeric Investors LLC | 0.84% | January 23, 2018 |
| November 23, 2017 | GSA Capital Partners LLP | 0.51% | December 27, 2017 |
| November 17, 2017 | Numeric Investors LLC | 0.71% | January 23, 2018 |
| November 13, 2017 | Marshall Wace LLP | 0.78% | January 4, 2018 |
| November 13, 2017 | Numeric Investors LLC | 0.62% | January 23, 2018 |
| November 8, 2017 | Marshall Wace LLP | 0.89% | January 4, 2018 |
| November 3, 2017 | GSA Capital Partners LLP | 0.49% | November 7, 2017 |
| October 27, 2017 | Marshall Wace LLP | 0.91% | January 4, 2018 |
| October 25, 2017 | GSA Capital Partners LLP | 0.50% | November 7, 2017 |
| October 16, 2017 | Marshall Wace LLP | 0.80% | January 4, 2018 |
| October 12, 2017 | Marshall Wace LLP | 0.79% | January 4, 2018 |
| October 6, 2017 | Marshall Wace LLP | 0.80% | January 4, 2018 |
| September 28, 2017 | Numeric Investors LLC | 0.50% | January 23, 2018 |
| September 25, 2017 | Marshall Wace LLP | 0.79% | January 4, 2018 |
| September 15, 2017 | Oxford Asset Management LLP | 0.49% | September 19, 2017 |
| September 14, 2017 | Numeric Investors LLC | 0.47% | September 18, 2017 |
| September 8, 2017 | Marshall Wace LLP | 0.89% | January 4, 2018 |
| September 4, 2017 | GSA Capital Partners LLP | 0.49% | September 6, 2017 |
| August 31, 2017 | GSA Capital Partners LLP | 0.51% | September 6, 2017 |
| August 30, 2017 | Marshall Wace LLP | 0.99% | January 4, 2018 |
| August 18, 2017 | Marshall Wace LLP | 1.09% | January 4, 2018 |
| August 18, 2017 | Numeric Investors LLC | 0.50% | September 18, 2017 |
| August 17, 2017 | Citadel Advisors II LLC | 0.49% | August 21, 2017 |
| August 14, 2017 | Marshall Wace LLP | 1.18% | January 4, 2018 |
| August 8, 2017 | Marshall Wace LLP | 1.27% | January 4, 2018 |
| July 27, 2017 | Marshall Wace LLP | 1.39% | January 4, 2018 |
| July 27, 2017 | Citadel Advisors II LLC | 0.50% | August 21, 2017 |
| July 21, 2017 | Marshall Wace LLP | 1.45% | January 4, 2018 |
| July 17, 2017 | Marshall Wace LLP | 1.54% | January 4, 2018 |
| July 17, 2017 | Citadel Advisors II LLC | 0.48% | July 19, 2017 |
| July 7, 2017 | Marshall Wace LLP | 1.61% | January 4, 2018 |
| July 4, 2017 | Citadel Advisors II LLC | 0.50% | July 19, 2017 |
| June 26, 2017 | Marshall Wace LLP | 1.57% | January 4, 2018 |
| June 22, 2017 | Citadel Advisors II LLC | 0.47% | June 26, 2017 |
| June 16, 2017 | Millennium International Management LP | 0.48% | June 20, 2017 |
Other companies sold short in France
- Ubisoft Entertainment 13.90% of the capital sold short
- Valeo 10.92% of the capital sold short
- Teleperformance 8.94% of the capital sold short
- Renault 6.44% of the capital sold short
- FDJ United 6.17% of the capital sold short
- Remy Cointreau 5.36% of the capital sold short
- Viridien 5.25% of the capital sold short
- Alstom 5.23% of the capital sold short
- Abivax 5.04% of the capital sold short
- Worldline 4.48% of the capital sold short
- Vusiongroup 4.08% of the capital sold short
- Forvia 4.06% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Innate Pharma, source AMF, data as at January 28, 2022, https://www.quivad.com/action/innate-pharma?page=2